Sort
48,018 grants matching “immunotherapy”
Mechanisms of immune evasion in T-cell acute lymphoblastic leukemia and its therapeutic implications
$405,748Birgit Knoechel · Dana-Farber Cancer Inst · R01 · FY2022 · CA
IMMUNOTHERAPY PROTECTION &VACCINES FOR HEPATITIS C
$405,730Rockefeller University · R01 · FY2003 · CA
T-Cell Responses Predict Influenza Risk in Older Adults
$405,725Janet E. McElhaney · University Of Connecticut Sch Of Med/Dnt · R01 · FY2008 · AI
STAFF INVESTIGATORS
$405,685Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2012 · CA
Immunobiology of Myeloid and Lymphoid Cells
$405,666Charles L Sentman · Dartmouth College · T32 · FY2015 · AI
Identification of serum protein biomarkers by profiling N-glycoproteomes of patient-derived xenografts of clear cell renal cell carcinoma
$405,619James D Brooks · Stanford University · R21 · FY2021 · CA
Analytical tools for studying the tumor microenvironment leveraging spatial transcriptomics
$405,558Xiaoqing Yu · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2023 · CA
IN VITRO STUDIES OF HUMAN ANAPHYLAXIS
$405,552Johns Hopkins University · R01 · FY2002 · AI
Fcgamma mediated regulation of dendritic cell function
$405,516Kavita Dhodapkar · Yale University · R01 · FY2011 · AI
Fcgamma mediated regulation of dendritic cell function
$405,516Kavita Dhodapkar · Yale University · R01 · FY2012 · AI
Targeting metastatic tumors with engineered cellular therapies
$405,478Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2023 · CA
WILD TYPE P53-BASED ADJUVANT IMMUNOTHERAPY FOR SCCHN
$405,477Albert B Deleo · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · CA
Functional Activation of Low Affinity TILs
$405,441Jill E Slansky · University Of Colorado Denver · R01 · FY2023 · CA
Pathogensis of Bacterial corneal infection
$405,388Gerald B Pier · Brigham And Women'S Hospital · R01 · FY2009 · EY
Cell lineage as an indicator of immune response in neuroblastoma
$405,378Rani E George · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Cell lineage as an indicator of immune response in neuroblastoma
$405,378Rani E George · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Immunotherapy for Renal Cell Carcinoma
$405,348Marc S Ernstoff · Dartmouth College · R01 · FY2009 · CA
Immunotherapeutic Targeting CD74 as a Treatment for Stimulant Use Disorder
$405,334Renee Lynn Shirley · Virogenomics Biodevelopment, Inc. · R41 · FY2024 · DA
Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
$405,225Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
CLINICAL THERAPY TRIALS
$405,218Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2014 · CA
Data-driven inference of regulators for cytokine-mediated tumor killing
$405,202Peng Jiang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
$405,180Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Mechanisms of Disease Pathogenesis in Regulatory T cell Deficiency
$405,126Talal Amine Chatila · Boston Children'S Hospital · R01 · FY2014 · AI
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy
$405,116Zheng-Rong Lu · Case Western Reserve University · R01 · FY2024 · CA
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy
$405,115Zheng-Rong Lu · Case Western Reserve University · R01 · FY2025 · CA